Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for complex antigen expression

被引:49
作者
Fan, PY [1 ]
Dong, F [1 ]
Huang, YQ [1 ]
Zhong, GM [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78229 USA
关键词
D O I
10.1128/IAI.70.1.345-349.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia pneumoniae is a causative agent for many respiratory infections and has been associated with cardiovascular diseases in humans. The pathogenicity of C. pneumoniae is thought to depend on its ability to cause persistent infection and to evade host defense. Genome sequence analysis indicates that C pneumoniae encodes a homologue of a chlamydial protease-like activity factor from C trachomatis (CPAFct). We designated the C. pneumoniae homologue as CPAFcp. Recombinant CPAFcp was produced and found to degrade RFX5, a host transcription factor required for major histo compatibility complex (MHC) antigen expression. The degradation was inhibitable by lactacystin, an irreversible proteasome inhibitor. Furthermore, CPA-Fcp was secreted into host cytosol by C. pneumoniae organisms. Depletion of the C. pneumoniae-secreted CPAFcp with specific antibodies completely ablated the RFX5 degradation activity in the infected cells, suggesting that CPAFcp is necessary for the degradation of host transcription factors required for MHC antigen expression during C. pneumoniae infection. These observations have revealed a unique molecular mechanism for C. pneumoniae to evade host adaptive immunity that may aid in its persistence.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 32 条
[1]   Chlamydia pneumoniae infection in human monocytes [J].
Airenne, S ;
Surcel, HM ;
Alakärppä, H ;
Laitinen, K ;
Paavonen, J ;
Saikku, P ;
Laurila, A .
INFECTION AND IMMUNITY, 1999, 67 (03) :1445-1449
[2]   PERSISTENT CHLAMYDIAE - FROM CELL-CULTURE TO A PARADIGM FOR CHLAMYDIAL PATHOGENESIS [J].
BEATTY, WL ;
MORRISON, RP ;
BYRNE, GI .
MICROBIOLOGICAL REVIEWS, 1994, 58 (04) :686-699
[3]   Mouse models of C-pneumoniae infection and atherosclerosis [J].
Campbell, LA ;
Blessing, E ;
Rosenfeld, M ;
Lin, TM ;
Kuo, CC .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S508-S513
[4]   Inhibition of apoptosis in Chlamydia-infected cells: Blockade of mitochondrial cytochrome c release and caspase activation [J].
Fan, T ;
Lu, H ;
Hu, H ;
Shi, LF ;
McClarty, GA ;
Nance, DM ;
Greenberg, AH ;
Zhong, GM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :487-496
[5]   Collaborative multidisciplinary workshop report:: What questions regarding the role of Chlamydia pneumoniae in atherosclerosis and cardiovascular disease need to be addressed utilizing animal models? [J].
Fong, IW ;
Quinn, T ;
Blessing, E ;
Kuo, CC ;
Malinverni, R ;
Lauer, M ;
Mawhorter, S ;
Bachmaier, K ;
Rosenfeld, M ;
Taylor, C ;
Zhong, GM .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S519-S520
[6]   Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis [J].
Fong, IW .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S514-S518
[7]   The prevalence of chronic Chlamydia pneumoniae infection as detected by polymerase chain reaction in pharyngeal samples from patients with ischaemic heart disease [J].
Gabriel, AS ;
Gnarpe, H ;
Gnarpe, J ;
Hallander, H ;
Nyquist, O ;
Martinsson, A .
EUROPEAN HEART JOURNAL, 1998, 19 (09) :1321-1327
[8]   MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION [J].
GERMAIN, RN .
CELL, 1994, 76 (02) :287-299
[9]  
Gieffers J, 2001, CIRCULATION, V103, P351
[10]   Background and current knowledge of Chlamydia pneumoniae and atherosclerosis [J].
Grayston, JT .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S402-S410